Publications

22 November

Public Return on Public Investment: Realities & Recommendations

4 October

AMR in the EU

4 October

AMR in the Netherlands

2 October

A One Health Perspective to AMR

1 September

Sexual and Reproductive Health Commodities in the DRC

15 August

Adolescent-Friendly Services in Tanzania

15 August

Sexual and Reproductive Health Commodities in Tanzania

2 August

TRIPS Flexibilities Navigator User Guide

1 August

SRH Commodities in Marsabit County, Kenya

1 August

SRH Commodities in Mandera County, Kenya

1 August

Response to European Consultation on Intellectual Property

1 August

SRH Commodities in Isiolo County, Kenya

15 July

Adolescent-Friendly Health Services in Kenya

29 June

The EU AI Liability Directive

15 June

Adolescent-Friendly Health Services in Zambia

15 June

Sexual and Reproductive Health Commodities in Zambia

7 June

IP in a Post-pandemic World

1 June

Adolescent-Friendly Health Services in Rwanda

1 June

Sexual and Reproductive Health Commodities in Rwanda

23 May

Glargine Insulin: Prices People Pay

26 April

Antimicrobial Resistance: A Multifaceted Approach

24 April

Annual Report 2022

6 April

National diabetes programme: Tanzania’s Transition

5 April

Promoting Health Rights and Access to Medicines in Europe

6 March

Factsheet: The EU Medical Devices Regulation and the AI Act

24 January

Diagnostics to Address Antimicrobial Resistance

25 November

Snakebite Prevention: Safiya’s 8 Secrets

21 November

Licensing and Access to Health Technologies

19 October

The TRIPS Agreement Laid Bare

3 October

Missing Clinical Trial Data in Europe